Hyperparathyroidism at 1 year after kidney transplantation is associated with graft loss.

Philip Crepeau, Xiaomeng Chen, Rhea Udyavar, Lilah F Morris-Wiseman, Dorry L Segev, Mara McAdams-DeMarco, Aarti Mathur

Surgery 2023 Jan

filter terms:

adult (2)

cohort (1)

cox models (2)

dialysis (2)

graft (7)

humans (1)

mortality (2)

patients (6)

race (3)

risk factors (1)

Sizes of these terms reflect their relevance to your search.

Hyperparathyroidism persists in many patients after kidney transplantation. The purpose of this study was to evaluate the association between post-transplant hyperparathyroidism and kidney transplantation outcomes. We identified 824 participants from a prospective longitudinal cohort of adult patients who underwent kidney transplantation at a single institution between December 2008 and February 2020. Parathyroid hormone levels before and after kidney transplantation were abstracted from medical records. Post-transplant hyperparathyroidism was defined as parathyroid hormone level ≥70 pg/mL 1 year after kidney transplantation. Cox proportional hazards models were used to estimate the adjusted hazard ratios of mortality and death-censored graft loss by post-transplant hyperparathyroidism. Models were adjusted for age, sex, race/ethnicity, college education, parathyroid hormone level before kidney transplantation, cause of kidney failure, and years on dialysis before kidney transplantation. A Wald test for interactions was used to evaluate the risk of death-censored graft loss by age, sex, and race. Of 824 recipients, 60.9% had post-transplant hyperparathyroidism. Compared with non-hyperparathyroidism patients, those with post-transplant hyperparathyroidism were more likely to be Black (47.2% vs 32.6%), undergo dialysis before kidney transplantation (86.9% vs 76.6%), and have a parathyroid hormone level ≥300 pg/mL before kidney transplantation (26.8% vs 9.5%) (all P < .001). Patients with post-transplant hyperparathyroidism had a 1.6-fold higher risk of death-censored graft loss (adjusted hazard ratio = 1.60, 95% confidence interval: 1.02-2.49) compared with those without post-transplant hyperparathyroidism. This risk more than doubled in those with parathyroid hormone ≥300 pg/mL 1 year after kidney transplantation (adjusted hazard ratio = 4.19, 95% confidence interval: 1.95-9.03). The risk of death-censored graft loss did not differ by age, sex, or race (all Pinteraction > .05). There was no association between post-transplant hyperparathyroidism and mortality. The risk of graft loss was significantly higher among patients with post-transplant hyperparathyroidism when compared with patients without post-transplant hyperparathyroidism. Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Citation

Philip Crepeau, Xiaomeng Chen, Rhea Udyavar, Lilah F Morris-Wiseman, Dorry L Segev, Mara McAdams-DeMarco, Aarti Mathur. Hyperparathyroidism at 1 year after kidney transplantation is associated with graft loss. Surgery. 2023 Jan;173(1):138-145